Empyema thoracis.
dc.contributor.author | Balachandran, A | en_US |
dc.contributor.author | Shivbalan, So | en_US |
dc.contributor.author | Thangavelu, S | en_US |
dc.contributor.author | Vijayasekaran, D | en_US |
dc.contributor.author | Subramnayam, L | en_US |
dc.date.accessioned | 2003-10-03 | en_US |
dc.date.accessioned | 2009-05-30T16:20:19Z | |
dc.date.available | 2003-10-03 | en_US |
dc.date.available | 2009-05-30T16:20:19Z | |
dc.date.issued | 2003-10-03 | en_US |
dc.description.abstract | Parapneumonic effusion and empyema thoracis remains a significant source of morbidity in children, though the overall incidence of empyema thoracis has decreased in the past two decades. These conditions pose a dilemma regarding evaluation and treatment for the treating physician. This article discusses the practical strategies in the management of empyema thoracis in children. | en_US |
dc.description.affiliation | Kanchi Kamakoti Childs Trust Hospital, Chennai, India. dr_abalachandran@hotmail.com | en_US |
dc.identifier.citation | Balachandran A, Shivbalan S, Thangavelu S, Vijayasekaran D, Subramnayam L. Empyema thoracis. Indian Journal of Pediatrics. 2003 Oct; 70(10): 803-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/84472 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://medind.nic.in/icb/icbai.shtml | en_US |
dc.subject.mesh | Anti-Infective Agents --therapeutic use | en_US |
dc.subject.mesh | Biopsy, Needle | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Combined Modality Therapy | en_US |
dc.subject.mesh | Drug Administration Schedule | en_US |
dc.subject.mesh | Empyema, Pleural --microbiology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Pleural Cavity --pathology | en_US |
dc.subject.mesh | Staphylococcal Infections --microbiology | en_US |
dc.subject.mesh | Thoracostomy --methods | en_US |
dc.title | Empyema thoracis. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1